In vitro transcription/translation analysis for the identification of translation-terminating mutations.
Luce
M C
MC
Myriad Genetics, Salt Lake City, UT, USA.
Binnie
C G
CG
Kam-Morgan
L N
LN
Cayouette
M C
MC
D025601:Adenomatous Polyposis Coli Protein; D018388:Codon, Terminator / Q000032:analysis*; D015179:Colorectal Neoplasms / Q000235:genetics; D003598:Cytoskeletal Proteins / Q000235:genetics; D004252:DNA Mutational Analysis / Q000379:methods*; D004268:DNA-Binding Proteins; D006801:Humans; D008214:Lymphocytes / Q000502:physiology; D051718:MutS Homolog 2 Protein; D009154:Mutation; D009386:Neoplastic Syndromes, Hereditary / Q000235:genetics; D016133:Polymerase Chain Reaction / Q000379:methods*; D014176:Protein Biosynthesis; D011518:Proto-Oncogene Proteins / Q000235:genetics; D014158:Transcription, Genetic
D025601:Adenomatous Polyposis Coli Protein; D018388:Codon, Terminator; D003598:Cytoskeletal Proteins; D004268:DNA-Binding Proteins; D011518:Proto-Oncogene Proteins; C497172:MSH2 protein, human; D051718:MutS Homolog 2 Protein